>
Skip navigation links
Home
Exposition
i2 Summit 2009
Valvular Heart Disease 
As the population ages, cardiologists are seeing more and more patients with valvular heart disease. Learn everything you need to know about mitral, aortic and tricuspid valve disease, including pathoanatomy, imaging choices and treatment challenges. Approach clinical decision-making with fresh insight as you learn what experts have to say about when to refer for surgery, expanding options in interventional therapy and controversies in the selection of replacement heart valves. You might just call it a Valvapalooza!

HOT TOPICS

Aortic Valve Disease

  • Imaging advances
  • Percutaneous vs. surgical therapies
  • Role of watchful waiting

Mitral Valve Disease

  • Degenerative and ischemic mitral regurgitation
  • Surgery: Why wait so long?
  • Latest percutaneous approaches to mitral valve repair

Tricuspid Valve Disease

  • Risks associated with tricuspid regurgitation
  • Weighing the treatment options


ClinCard Spotlight

  • Cardiac MR for evaluation of hypertrophic cardiomyopathy
  • Mitral valve repair/CABG: Surgical decision-making
  • Hear from master clinicians on asymptomatic valvular heart disease


Integrated Imaging Spotlight

  • Update on imaging technology for valve disease: 3D TEE, TTE, and flow Doppler; CT, CMR
  • Clinical applications of imaging technology: Asymptomatic severe valve disease
  • Case presentations: 2D/3D echo in complex mitral valve prolapse; echo and CMR in severe aortic regurgitation


More Highlights

  • Hypertrophic obstructive cardiomyopathy: What is the best treatment approach? What are the outcomes?
  • Prosthetic heart valves: Mechanical vs. biologic valves, stented vs. stentless biologic valves


Learn from the Experts

  • Atrial fibrillation and valve disease: Dual surgical intervention?
  • Endocarditis: Is early surgery better; is mitral valve repair an option?
  • Timing of valve intervention: Should we wait for symptoms?

 

PLUS
With Full-Access registration, i2 Summit also offers:

  • Percutaneous treatment of aortic stenosis and mitral regurgitation
  • Focus on hemodynamics
  • Late Breaking Clinical Trials each morning
  • Interactive case presentations and discussions throughout the day on clinical strategies of importance to both interventional and general cardiologists